Finance

Lists
RPGLIFE:NSE
RPG Life Sciences Ltd
₹2,559.60
-1.39%
(-36.10) 1D
Nov 6, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for RPGLIFE...
Open
₹2,580.00
High
₹2,580.00
Low
₹2,520.10
Mkt. cap
42.24B
Avg. vol.
38.81K
Volume
6.97K
Dividend
0.94%
Quarterly dividend
₹6.00
Ex-dividend date
Jul 9, 2026
P/E ratio
38.13
52-wk high
₹3,127.80
52-wk low
₹1,733.00
EPS
₹67.13
Shares outstanding
16.54M
No. of employees
1K
Open
₹2,580.00
High
₹2,580.00
Low
₹2,520.10
Mkt. cap
42.24B
Avg. vol.
38.81K
Volume
6.97K
Dividend
0.94%
Quarterly dividend
₹6.00
Ex-dividend date
Jul 9, 2026
P/E ratio
38.13
52-wk high
₹3,127.80
52-wk low
₹1,733.00
EPS
₹67.13
Shares outstanding
16.54M
No. of employees
1K
News stories
From web sources and news partners
Profile
RPG Life Sciences is an Indian pharmaceutical company. Formerly known as Searle Ltd, RPG Life Sciences is part of RPG Enterprises. It has its corporate office in RPG House in Worli, Mumbai. Its three major activities are the manufacturing and marketing of bulk drugs, also known as active pharmaceutical ingredients; pharmaceutical formulation; and fermentation and biotechnology. RPGLS is present in the domestic as well as the international market. It exports its products primarily to Europe, Latin America, Australia and South East Asian countries. Wikipedia
About RPG Life Sciences Ltd
CEO-
Employees1.37K
Founded1993
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Last report
Oct 30, 2026
Fiscal period
Q2 2027
- / -
Revenue / Est. (INR)
2.12B / -
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.80B
1.77B
1.96B
2.12B
Cost of goods sold
649.00M
661.00M
681.50M
721.40M
Cost of revenue
649.00M
661.00M
681.50M
721.40M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
353.20M
570.90M
377.60M
440.90M
Operating expense
807.50M
835.00M
901.50M
1.06B
Total operating expenses
1.46B
1.50B
1.58B
1.78B
Operating income
343.80M
273.30M
373.90M
336.20M
Other non operating income
34.10M
-101.90M
47.00M
42.60M
EBT including unusual items
291.20M
402.00M
414.60M
370.40M
EBT excluding unusual items
375.40M
277.30M
414.60M
370.40M
Income tax expense
69.90M
103.00M
107.00M
88.20M
Effective tax rate
24.00%
25.62%
25.81%
23.81%
Other operating expenses
400.50M
206.70M
464.90M
549.90M
Net income
221.30M
299.00M
307.60M
266.00M
Net profit margin
12.29%
16.90%
15.72%
12.57%
Earnings per share
-
-
-
-
Interest and investment income
-
96.70M
-
-
Interest expense
-2.50M
-3.90M
-6.30M
-8.40M
Net interest expenses
-2.50M
92.80M
-6.30M
-8.40M
Depreciation and amortization charges
53.80M
57.40M
59.00M
68.00M
EBITDA
395.75M
325.80M
426.40M
399.70M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps